Keywords
Last Name
Institution

Joseph Frindik

TitleAssociate Professor
InstitutionUniversity of Arkansas for Medical Sciences
DepartmentPediatrics, College of Medicine
DivisionPeds Endocrinology
AddressG-4022 ACH Administration
1900 Maryland Street
Mail Slot # 512-6
Little Rock AR 72202
Phone501-364-1430
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Frindik J Paul. 17 alpha hydroxylase deficiency. 2012.
    2. Frindik J Paul. 3 beta hydroxysteroid dehydrogenase deficiency. 2012.
    3. Frindik J Paul. Contemporary Trends in ADHD Research. Endocrine Dysfunction and Growth in Attention Deficit Hyperactivity Disorder. 2012.
    4. Kemp SF, Frindik JP. Emerging options in growth hormone therapy: an update. Drug Des Devel Ther. 2011; 5:411-9. PMID: 21966214; PMCID: PMC3180516.
    5. Thrailkill KM, Moreau CS, Swearingen C, Rettiganti M, Edwards K, Morales AE, Kemp SF, Frindik JP, Fowlkes JL. Insulin pump therapy started at the time of diagnosis: effects on glycemic control and pancreatic ß-cell function in type 1 diabetes. Diabetes Technol Ther. 2011 Oct; 13(10):1023-30. PMID: 21718094.
      View in: PubMed
    6. Kemp, Stephen F, Frindik, J Paul. Emerging Options in Growth Hormone Therapy. Drug Design, Development and Therapy. 2011.
    7. Thrailkill, KM, Moreau, C, Swearingen, C, Rettiganti, M, Edwards, K, Morales, AE, Kemp, SF, Frindik, JP, Fowlkes, JL. Insulin pump therapy started at the time of diagnosis: Effects on glycemic control and pancreatic beta cell function in type 1 diabetes. Diabetes Technology and Therapeutics. 2011; 13(10):1-8.
    8. Frindik JP, Kemp SF. Managing idiopathic short stature: role of somatropin (rDNA origin) for injection. Biologics. 2010 Jun 24; 4:147-55. PMID: 20631818; PMCID: PMC2898102.
    9. Frindik JP. 17 alpha hydroxylase deficiency. 2010.
    10. Frindik JP. 3 beta hydroxysteroid dehydrogenase deficiency. 2010.
    11. Frindik JP, Morales A, Fowlkes J, Kemp S, Thrailkill K, Lippe B, Dana K. Stimulant medication use and response to growth hormone therapy: an NCGS database analysis. Horm Res. 2009; 72(3):160-6. PMID: 19729947.
      View in: PubMed
    12. Frindik JP, Fowlkes, J, Kemp, SF, Thrailkill, K, Morales, A, Dana, K. Increasing Prevalence of Stimulant Medication Use in Children with Growth Hormone Deficiency or Idiopathic Short Stature: An NCGS Database Analysis Summary. Hormone Research. 2009; 72:160--166.
    13. Thompson S, Morales-Pozzo A, Frindik JP, Palacios J, Moses A. Why Do I Need to Write Objectives?. 2008.
    14. Kemp SF, Frindik JP. Essential Pediatric Endocrinology and Inborn Errors of Metabolism. Disorders of Growth. 2008.
    15. Kemp, SF, Frindik, JP. The Role of Growth Hormone and Insulin-Like Growth Factor-1 in the Treatment of Idiopathic Short Stature. Current Medical Literature:. 2008.
    16. Thrailkill KM, Bunn RC, Moreau CS, Cockrell GE, Simpson PM, Coleman HN, Frindik JP, Kemp SF, Fowlkes JL. Matrix metalloproteinase-2 dysregulation in type 1 diabetes. Diabetes Care. 2007 Sep; 30(9):2321-6. PMID: 17563344; PMCID: PMC2239013.
    17. Nimmo TA, Morales AE, Sayed K, Frindik JP, Kemp SF. Hypercalcemia in an 11-year-old girl. Endocr Pract. 2007 Mar-Apr; 13(2):198-201. PMID: 17490937.
      View in: PubMed
    18. Frindik JP. Diagnosis and Management of Hypoglycemia [serial online]. 2007.
    19. Frindik JP. Growth Hormone Deficiency: Pediatric to Adult Transition [serial online]. 2007.
    20. Kemp SF, Frindik JP. The Role of Growth Hormone and Insulin-Like Growth Factor-1 in the Treatment of Idiopathic Short Stature. Growth, Growth Hormone & Metabolism. 2006; 1(4):98-102.
    21. Frindik JP, Kemp SF, Hunold JJ. Near adult heights after growth hormone treatment in patients with idiopathic short stature or idiopathic growth hormone deficiency. J Pediatr Endocrinol Metab. 2003 May; 16 Suppl 3:607-12. PMID: 12795361.
      View in: PubMed
    22. Frindik JP, Williams JP, Johnson RL, Dykman RA. Parental perception and factors associated with glycemic control in pediatric patients with type 1 diabetes. Endocr Pract. 2002 Mar-Apr; 8(2):105-8. PMID: 11942774.
      View in: PubMed
    23. Frindik JP. Pituitary Morphologic Anomalies and Magnetic Resonance Imaging in Pediatric Growth Hormone Deficiency. The Endocrinologist. 2001; 4:289-295.
    24. Frindik JP, Baptista J. Adult height in growth hormone deficiency: historical perspective and examples from the national cooperative growth study. Pediatrics. 1999 Oct; 104(4 Pt 2):1000-4. PMID: 10506251.
      View in: PubMed
    25. Blethen SL, Frindik JP, Baptista J. Treatment of Childhood Growth Hormone (GH) Deficiency: Efficacy and Innovations. Revista Argentina de Endocrinología y Metabolismo. 1999; 36:24–28.
    26. Frindik JP, Kemp SF, Sy JP. Effects of recombinant human growth hormone on height and skeletal maturation in growth hormone-deficient children with and without severe pretreatment bone age delay. Horm Res. 1999; 51(1):15-9. PMID: 10095164.
      View in: PubMed
    27. Elders MJ, Scott CR, Frindik JP, Kemp SF. Clinical workup for precocious puberty. Lancet. 1997 Aug 16; 350(9076):457-8. PMID: 9274578.
      View in: PubMed
    28. Scott CR, Frindik JP, Kemp SF, Kearns GL. Recurrent hypoglycemia and obesity in an adolescent--insulinoma or imitator? Clin Pediatr (Phila). 1996 Mar; 35(3):157-60. PMID: 8904491.
      View in: PubMed
    29. Frindik JP, Kemp SF, Pihoker C. Effective use of magnetic resonance imaging in the assessment of children with possible growth hormone deficiency. Endocr Pract. 1996 Jan-Feb; 2(1):8-12. PMID: 15251557.
      View in: PubMed
    30. Frindik JP, Arnold WC, Ellis E. Chronic Low Dose Growth Hormone Treatment Stimulates Both Hypertrophy and Hyperplasia of Remnant Kidneys in Uraemic Rats. Clin Drug Investig. 1995 Sep; 10(3):183-7. PMID: 27519203.
      View in: PubMed
    31. Frindik JP, Arnold WC, Ellis E. Chronic low-dose growth hormone stimulates both hypertrophy and hyperplasia of remnant kidneys in uremic rats. Clinical Drug Investigation. 1995; 10(3):1–5.
    32. Frindik JP, Kemp SF, Kearns GL. Epidermal growth factor concentrations in growth hormone deficient children: effects of single versus multiple injections of growth hormone. Drug Investigation. 1994; 8(4):257–262.
    33. Kemp SF, Frindik JP, Kearns GL. Clinical and biochemical correlates of growth associated with short-term administration of methionyl growth hormone. Dev Pharmacol Ther. 1993; 20(3-4):199-204. PMID: 7828454.
      View in: PubMed
    34. Frindik JP, Kemp SF, Kearns FS, Hale B. Growth screening. A positive medical experience. Clin Pediatr (Phila). 1992 Aug; 31(8):497-500. PMID: 1643769.
      View in: PubMed
    35. Kemp SF, Frindik JP. Effect of metabolic control on serum protein concentrations in diabetes. Acta Paediatr Scand. 1991 Oct; 80(10):938-43. PMID: 1755300.
      View in: PubMed
    36. Kearns GL, Kemp SF, Frindik JP. Single and multiple dose pharmacokinetics of methionyl growth hormone in children with idiopathic growth hormone deficiency. J Clin Endocrinol Metab. 1991 May; 72(5):1148-56. PMID: 2022713.
      View in: PubMed
    37. Ellis EN, Kemp SF, Frindik JP, Elders MJ. Glomerulopathy in patient with Donohue syndrome (leprechaunism). Diabetes Care. 1991 May; 14(5):413-4. PMID: 1711953.
      View in: PubMed
    38. Ellis EE, Kemp SF, Frindik JP, Elders MJ. Glomerulopathy in Donohue Syndrome (Leprechaunism). Diabetes Care. 1991; 14(5):413-414.
    39. Arnold WC, Shirkey B, Frindik JP, Ellis E. Effect of growth hormone on kidney growth and glomerular structure. Ped Nephrology. 1991; 5:529–532.
    40. Frindik JP, Kemp SF, Elders MJ. The effect of growth hormone on urinary epidermal growth factor excretion in growth hormone deficient children. J Ped Endocrinology. 1989; 3:171–173.
    41. Frindik JP, Kemp SF, Elders MJ, Morris M. The effect of growth hormone on lipid profiles of growth hormone deficient children. J Ped Endocrinology. 1989; 3:167–170.
    42. Vesely DL, Schedewie HK, Kemp SF, Frindik JP, Elders MJ. Decreased cyclic guanosine 3',5' monophosphate and guanylate cyclase activity in leprechaunism: evidence for a postreceptor defect. Pediatr Res. 1986 Apr; 20(4):329-31. PMID: 2871543.
      View in: PubMed
    43. Frindik JP, Kemp SF, Fiser RH, Schedewie H, Elders MJ. Phenotypic expression in Donohue syndrome (leprechaunism): a role for epidermal growth factor. J Pediatr. 1985 Sep; 107(3):428-30. PMID: 3875706.
      View in: PubMed
    44. Frindik JP, Kemp SF, Fiser RH, Schedewie H, Elders MJ. Phenotypic expression in Donahue syndrome (leprechaunism): a role for epidermal growth factor. J Pediatr. 1985; 107(3):428 - 430.
    45. Frindik JP, Kemp SF, Fiser RH, Schedewie HK, Elders MJ. Phenotypic expression in Donahue's syndrome (Leprechaunism): a role for epidermal growth factor. J Pediatrics. 1985; 107:428–430.
    46. Frindik JP, Kassner DA, Pirkle DA, Kemp SF, Hoff C. Comparison of Visidex and Chemstrip bG with Beckman Glucose Analyzer determination of blood glucose. Diabetes Care. 1983 Nov-Dec; 6(6):536-9. PMID: 6653310.
      View in: PubMed
    47. Kemp, Stephen F., Frindik, J. Paul, Ranke, Michael. Essential Pediatric Endocrinology and Inborn Errors of Metabolism. Disorders of Growth.
    Frindik's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description
    Physical Neighbors Expand Description
    _